Ballentine Partners LLC Increases Stake in Sanofi (NASDAQ:SNY)

Ballentine Partners LLC increased its stake in Sanofi (NASDAQ:SNY) by 22.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,446 shares of the company’s stock after acquiring an additional 2,802 shares during the period. Ballentine Partners LLC’s holdings in Sanofi were worth $745,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Northwest Investment Counselors LLC purchased a new stake in shares of Sanofi during the 3rd quarter worth about $29,000. Concord Wealth Partners raised its holdings in Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after buying an additional 363 shares during the period. Fortitude Family Office LLC lifted its position in Sanofi by 708.6% during the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after buying an additional 659 shares in the last quarter. Sunbelt Securities Inc. increased its position in shares of Sanofi by 72.1% in the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after acquiring an additional 313 shares in the last quarter. Finally, Versant Capital Management Inc acquired a new stake in shares of Sanofi in the fourth quarter worth $54,000. 14.04% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two equities research analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $57.50.

Sanofi Stock Down 0.3 %

Shares of NASDAQ:SNY opened at $51.51 on Thursday. The company has a market capitalization of $130.72 billion, a price-to-earnings ratio of 26.28, a price-to-earnings-growth ratio of 1.25 and a beta of 0.57. The company has a 50 day moving average of $48.53 and a two-hundred day moving average of $52.16. Sanofi has a 52-week low of $45.22 and a 52-week high of $58.97. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17.

Sanofi (NASDAQ:SNY) last released its quarterly earnings results on Friday, October 25th. The company reported $1.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $1.35. The business had revenue of $13.44 billion during the quarter, compared to analyst estimates of $16.59 billion. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. The business’s revenue was up 12.3% on a year-over-year basis. During the same period last year, the business earned $2.55 EPS. As a group, analysts forecast that Sanofi will post 3.92 earnings per share for the current fiscal year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.